Synthesis of bicyclic 1,4-thiazepines as novel anti-Trypanosoma brucei brucei agents.
暂无分享,去创建一个
Vojtech Jancik | Andrea Medeiros | G. Salinas | Jaime Franco | M. Comini | Cecilia Saiz | Pablo Fontán | Gustavo Salinas | Franco Vairoletti | Jennifer Meléndrez | Carlos Tabárez | Jaime Franco | Marcelo A Comini | Jenny Saldaña | Graciela Mahler | V. Jancik | C. Tabarez | Graciela Mahler | Franco Vairoletti | C. Saiz | A. Medeiros | J. Saldaña | Pablo Fontán | Jennifer Meléndrez
[1] Elias S. J. Arnér,et al. Preparation and assay of mammalian thioredoxin and thioredoxin reductase. , 1999, Methods in enzymology.
[2] L. Goupil,et al. Introduction: drug discovery and development for neglected diseases. , 2014, Chemical reviews.
[3] L. M. Lima,et al. Hybrid furoxanyl N-acylhydrazone derivatives as hits for the development of neglected diseases drug candidates. , 2013, European journal of medicinal chemistry.
[4] C. Saiz,et al. Imine Domino Reactions Generate Novel Scaffolds: Fused Bisthiazolidines or Bisthiiranes , 2012 .
[5] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[6] G. Salinas,et al. Discovering Echinococcus granulosus thioredoxin glutathione reductase inhibitors through site-specific dynamic combinatorial chemistry , 2013, Molecular Diversity.
[7] Karen Perelmuter,et al. In vitro activity and mode of action of distamycin analogues against African trypanosomes. , 2017, European journal of medicinal chemistry.
[8] Terry K. Smith,et al. Development of Simplified Heterocyclic Acetogenin Analogues as Potent and Selective Trypanosoma brucei Inhibitors , 2016, ChemMedChem.
[9] R. Loddo,et al. Synthesis, pharmacological and antiviral activity of 1,3-thiazepine derivatives. , 2009, European journal of medicinal chemistry.
[10] Anuj Sharma,et al. Thia‐Michael Addition: An Emerging Strategy in Organic Synthesis , 2018 .
[11] D. Maloney,et al. Synthesis of Oxadiazole-2-oxide Analogues as Potential Antischistosomal Agents. , 2009, Tetrahedron letters.
[12] V. Moreno,et al. New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents. , 2012, Dalton transactions.
[13] Allan M Jordan,et al. The medicinal chemist's toolbox: an analysis of reactions used in the pursuit of drug candidates. , 2011, Journal of medicinal chemistry.
[14] Anuj Sharma,et al. Benzothiazepines: chemistry of a privileged scaffold , 2015 .
[15] P. Wipf,et al. Selenosemicarbazones as potent cruzipain inhibitors and their antiparasitic properties against Trypanosoma cruzi , 2012 .
[16] C. Humblet,et al. Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.
[17] V. Gladyshev,et al. Identification of Thioredoxin Glutathione Reductase Inhibitors That Kill Cestode and Trematode Parasites , 2012, PloS one.
[18] Tyler E. Benedum,et al. A practical method for oxazole synthesis by cycloisomerization of propargyl amides. , 2004, Organic letters.
[19] L. Suescun,et al. Synthesis and in vitro anthelmintic activity against Nippostrongylus brasiliensis of new 2-amino-4-hydroxy-delta-valerolactam derivatives. , 1997, Farmaco.
[20] Adam R Renslo,et al. Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.
[21] M. Tyers,et al. Caenorhabditis elegans is a useful model for anthelmintic discovery , 2015, Nature Communications.
[22] R. Bonomo,et al. Bisthiazolidines: A Substrate-Mimicking Scaffold as an Inhibitor of the NDM-1 Carbapenemase. , 2015, ACS infectious diseases.
[23] J. Baldwin,et al. Rules for ring closure. , 1977, Ciba Foundation symposium.
[24] G. Sheldrick. A short history of SHELX. , 2008, Acta crystallographica. Section A, Foundations of crystallography.
[25] N. Trippodo,et al. Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. , 1997, Journal of medicinal chemistry.
[26] David R Spring,et al. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.
[27] E. Ferreira,et al. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity. , 2014, European journal of medicinal chemistry.
[28] Chuan-Xin Yu,et al. Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum , 2012, PloS one.
[29] George M. Sheldrick,et al. ShelXle: a Qt graphical user interface for SHELXL , 2011, Journal of applied crystallography.
[30] L. Domínguez,et al. Use of L4 larvae of Nippostrongylus brasiliensis for the in vivo screening of anthelmintic drugs. , 2000, Canadian journal of veterinary research = Revue canadienne de recherche veterinaire.
[31] Mahmoud Labib,et al. Synthesis and Surface Investigations of N-Substituted 2,5-Dithio-7-azabicyclo[2.2.1]heptanes on Gold Surfaces , 2012 .
[32] D. Moerman,et al. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity , 2016, PLoS neglected tropical diseases.
[33] E. Davioud‐Charvet,et al. Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target , 2007, PLoS medicine.
[34] L. Suescun,et al. Enantioselective synthesis of new oxazolidinylthiazolidines as enzyme inhibitors. , 2017, Tetrahedron, asymmetry.
[35] F. Lovering,et al. Escape from Flatland 2: complexity and promiscuity , 2013 .
[36] Y. Pommier,et al. Thiazolothiazepine inhibitors of HIV-1 integrase. , 1999, Journal of medicinal chemistry.
[37] H. Alper,et al. Remarkable synthesis of 2-(Z)-6-(E)-4H-[1,4]-thiazepin-5-ones by zwitteronic rhodium-catalyzed chemo- and regioselective cyclohyrocarbonylative ring expansion of acetylenic thiazoles. , 2001, Journal of the American Chemical Society.